Carrier Screening Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Carrier Screening Market: By Method (Molecular Screening Test, Biochemical Screening Test), Type of Carrier Screening (Expanded Carrier Screening, Targeted Disease Carrier Screening), Medical Condition (Cystic Fibrosis, Fragile X-Syndrome, Sickele Cell Disease, Spinal Muscular Atrophy, Alphathalassemia, Other Conditions (Tay Scah Disease)), Technology (Polymerase Chain Reaction (PCR), DNA Sequencing, Microarrays and Other Technologies), End User (Hospitals, Reference Laboratories, Physician Offices & Clinics and Other End Users) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category: Tag:

Report

Description

1. Executive Summary
2. Global Carrier Screening Market Introduction
2.1. Global Carrier Screening Market – Taxonomy
2.2. Global Carrier Screening Market –Definitions
2.2.1. Method
2.2.2. Type of Carrier Screening
2.2.3. Medical Condition
2.2.4. Technology
2.2.5. End-User
3. Global Carrier Screening Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Carrier Screening Market Dynamic Factors – Impact Analysis
3.6. Global Carrier Screening Market – Competition Landscape
4. Global Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Carrier Screening Market Forecast, By Method, 2017 – 2021 and Forecast, 2022 – 2028
5.1. Molecular Screening Test
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Biochemical Screening Test
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Carrier Screening Market Forecast, By Type of Carrier Screening, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Expanded Carrier Screening
6.1.1. Customized Panel Testing
6.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.1.3. Market Opportunity Analysis
6.1.2. Predesigned Panel Testing
6.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.2.3. Market Opportunity Analysis
6.2. Targeted Disease Carrier Screening
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Carrier Screening Market Forecast, By Medical Condition, 2017 – 2021 and Forecast, 2022 – 2028
7.1. Cystic Fibrosis
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Fragile X-Syndrome
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Sickele Cell Disease
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Spinal Muscular Atrophy
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Alphathalassemia
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Other Conditions (Tay Scah Disease)
7.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Carrier Screening Market Forecast, By Technology, 2017 – 2021 and Forecast, 2022 – 2028
8.1. Polymerase Chain Reaction (PCR)
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. DNA Sequencing
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Microarrays
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Other Technologies
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Carrier Screening Market Forecast, By End-User, 2017 – 2021 and Forecast, 2022 – 2028
9.1. Hospitals
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Reference Laboratories
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Physician Offices & Clinics
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Other End Users
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
10. Global Carrier Screening Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
10.1. North America
10.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Region, 2022 – 2028
11. North America Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
11.1. By Method Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.1. Molecular Screening Test
11.1.2. Biochemical Screening Test
11.2. By Type of Carrier Screening Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Expanded Carrier Screening
11.2.1.1. Customized Panel Testing
11.2.1.2. Predesigned Panel Testing
11.2.2. Targeted Disease Carrier Screening
11.3. By Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Cystic Fibrosis
11.3.2. Fragile X-Syndrome
11.3.3. Sickele Cell Disease
11.3.4. Spinal Muscular Atrophy
11.3.5. Alphathalassemia
11.3.6. Other Conditions (Tay Scah Disease)
11.4. By Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Polymerase Chain Reaction (PCR)
11.4.2. DNA Sequencing
11.4.3. Microarrays
11.4.4. Other Technologies
11.5. By End-User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Hospitals
11.5.2. Reference Laboratories
11.5.3. Physician Offices & Clinics
11.5.4. Other End Users
11.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 – 2028
11.8. North America Carrier Screening Market Dynamics – Trends
12. Europe Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
12.1. By Method Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.1. Molecular Screening Test
12.1.2. Biochemical Screening Test
12.2. By Type of Carrier Screening Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Expanded Carrier Screening
12.2.1.1. Customized Panel Testing
12.2.1.2. Predesigned Panel Testing
12.2.2. Targeted Disease Carrier Screening
12.3. By Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Cystic Fibrosis
12.3.2. Fragile X-Syndrome
12.3.3. Sickele Cell Disease
12.3.4. Spinal Muscular Atrophy
12.3.5. Alphathalassemia
12.3.6. Other Conditions (Tay Scah Disease)
12.4. By Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Polymerase Chain Reaction (PCR)
12.4.2. DNA Sequencing
12.4.3. Microarrays
12.4.4. Other Technologies
12.5. By End-User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Hospitals
12.5.2. Reference Laboratories
12.5.3. Physician Offices & Clinics
12.5.4. Other End Users
12.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Poland
12.6.8. Rest of Europe
12.7. Europe Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 – 2028
12.8. Europe Carrier Screening Market Dynamics – Trends
13. Asia-Pacific Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
13.1. By Method Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.1. Molecular Screening Test
13.1.2. Biochemical Screening Test
13.2. By Type of Carrier Screening Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Expanded Carrier Screening
13.2.1.1. Customized Panel Testing
13.2.1.2. Predesigned Panel Testing
13.2.2. Targeted Disease Carrier Screening
13.3. By Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Cystic Fibrosis
13.3.2. Fragile X-Syndrome
13.3.3. Sickele Cell Disease
13.3.4. Spinal Muscular Atrophy
13.3.5. Alphathalassemia
13.3.6. Other Conditions (Tay Scah Disease)
13.4. By Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Polymerase Chain Reaction (PCR)
13.4.2. DNA Sequencing
13.4.3. Microarrays
13.4.4. Other Technologies
13.5. By End-User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Hospitals
13.5.2. Reference Laboratories
13.5.3. Physician Offices & Clinics
13.5.4. Other End Users
13.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 – 2028
13.8. Asia-Pacific Carrier Screening Market Dynamics – Trends
14. Latin America Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
14.1. By Method Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.1. Molecular Screening Test
14.1.2. Biochemical Screening Test
14.2. By Type of Carrier Screening Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Expanded Carrier Screening
14.2.1.1. Customized Panel Testing
14.2.1.2. Predesigned Panel Testing
14.2.2. Targeted Disease Carrier Screening
14.3. By Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Cystic Fibrosis
14.3.2. Fragile X-Syndrome
14.3.3. Sickele Cell Disease
14.3.4. Spinal Muscular Atrophy
14.3.5. Alphathalassemia
14.3.6. Other Conditions (Tay Scah Disease)
14.4. By Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Polymerase Chain Reaction (PCR)
14.4.2. DNA Sequencing
14.4.3. Microarrays
14.4.4. Other Technologies
14.5. By End-User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Hospitals
14.5.2. Reference Laboratories
14.5.3. Physician Offices & Clinics
14.5.4. Other End Users
14.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Argentina
14.6.4. Rest of Latin America
14.7. Latin America Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 – 2028
14.8. Latin America Carrier Screening Market Dynamics – Trends
15. Middle East and Africa Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
15.1. By Method Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.1. Molecular Screening Test
15.1.2. Biochemical Screening Test
15.2. By Type of Carrier Screening Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.2.1. Expanded Carrier Screening
15.2.1.1. Customized Panel Testing
15.2.1.2. Predesigned Panel Testing
15.2.2. Targeted Disease Carrier Screening
15.3. By Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Cystic Fibrosis
15.3.2. Fragile X-Syndrome
15.3.3. Sickele Cell Disease
15.3.4. Spinal Muscular Atrophy
15.3.5. Alphathalassemia
15.3.6. Other Conditions (Tay Scah Disease)
15.4. By Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. Polymerase Chain Reaction (PCR)
15.4.2. DNA Sequencing
15.4.3. Microarrays
15.4.4. Other Technologies
15.5. By End-User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Hospitals
15.5.2. Reference Laboratories
15.5.3. Physician Offices & Clinics
15.5.4. Other End Users
15.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. Israel
15.6.3. South Africa
15.6.4. Rest of MEA
15.7. MEA Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 – 2028
15.8. MEA Carrier Screening Market Dynamics – Trends
16. Competition Landscape 
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Material & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Plastixx FFS Technologies
16.2.2. Centogene N.V
16.2.3. LifeCell International Pvt. Ltd.
16.2.4. Thermo Fisher Scientific Inc.
16.2.5. 23Andme Inc.
16.2.6. F. Hoffmann-La Roche AG
16.2.7. Abbott Laboratories
16.2.8. Illumina Inc.
16.2.9. Autogenomics Inc.
16.2.10. Myriad Genetics
16.2.11. Cepheid (Danaher Corporation)
16.2.12. Luminex Corporation
16.2.13. Sequenom Inc. (Laboratory Corporation of America Holdings)
17. Research Methodology
18. Key Assumptions and Acronyms

Frequently Asked Questions


Report

Company Profile

  • Plastixx FFS Technologies
  • Centogene N.V
  • LifeCell International Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
  • 23Andme Inc.
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Illumina Inc.
  • Autogenomics Inc.
  • Myriad Genetics
  • Cepheid (Danaher Corporation)
  • Luminex Corporation
  • Sequenom Inc. (Laboratory Corporation of America Holdings)

Description

1. Executive Summary
2. Global Carrier Screening Market Introduction
2.1. Global Carrier Screening Market – Taxonomy
2.2. Global Carrier Screening Market –Definitions
2.2.1. Method
2.2.2. Type of Carrier Screening
2.2.3. Medical Condition
2.2.4. Technology
2.2.5. End-User
3. Global Carrier Screening Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Carrier Screening Market Dynamic Factors – Impact Analysis
3.6. Global Carrier Screening Market – Competition Landscape
4. Global Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Carrier Screening Market Forecast, By Method, 2017 – 2021 and Forecast, 2022 – 2028
5.1. Molecular Screening Test
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Biochemical Screening Test
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Carrier Screening Market Forecast, By Type of Carrier Screening, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Expanded Carrier Screening
6.1.1. Customized Panel Testing
6.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.1.3. Market Opportunity Analysis
6.1.2. Predesigned Panel Testing
6.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.2.3. Market Opportunity Analysis
6.2. Targeted Disease Carrier Screening
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Carrier Screening Market Forecast, By Medical Condition, 2017 – 2021 and Forecast, 2022 – 2028
7.1. Cystic Fibrosis
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Fragile X-Syndrome
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Sickele Cell Disease
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Spinal Muscular Atrophy
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Alphathalassemia
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Other Conditions (Tay Scah Disease)
7.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Carrier Screening Market Forecast, By Technology, 2017 – 2021 and Forecast, 2022 – 2028
8.1. Polymerase Chain Reaction (PCR)
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. DNA Sequencing
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Microarrays
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Other Technologies
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Carrier Screening Market Forecast, By End-User, 2017 – 2021 and Forecast, 2022 – 2028
9.1. Hospitals
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Reference Laboratories
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Physician Offices & Clinics
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Other End Users
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
10. Global Carrier Screening Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
10.1. North America
10.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Region, 2022 – 2028
11. North America Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
11.1. By Method Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.1. Molecular Screening Test
11.1.2. Biochemical Screening Test
11.2. By Type of Carrier Screening Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Expanded Carrier Screening
11.2.1.1. Customized Panel Testing
11.2.1.2. Predesigned Panel Testing
11.2.2. Targeted Disease Carrier Screening
11.3. By Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Cystic Fibrosis
11.3.2. Fragile X-Syndrome
11.3.3. Sickele Cell Disease
11.3.4. Spinal Muscular Atrophy
11.3.5. Alphathalassemia
11.3.6. Other Conditions (Tay Scah Disease)
11.4. By Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Polymerase Chain Reaction (PCR)
11.4.2. DNA Sequencing
11.4.3. Microarrays
11.4.4. Other Technologies
11.5. By End-User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Hospitals
11.5.2. Reference Laboratories
11.5.3. Physician Offices & Clinics
11.5.4. Other End Users
11.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 – 2028
11.8. North America Carrier Screening Market Dynamics – Trends
12. Europe Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
12.1. By Method Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.1. Molecular Screening Test
12.1.2. Biochemical Screening Test
12.2. By Type of Carrier Screening Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Expanded Carrier Screening
12.2.1.1. Customized Panel Testing
12.2.1.2. Predesigned Panel Testing
12.2.2. Targeted Disease Carrier Screening
12.3. By Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Cystic Fibrosis
12.3.2. Fragile X-Syndrome
12.3.3. Sickele Cell Disease
12.3.4. Spinal Muscular Atrophy
12.3.5. Alphathalassemia
12.3.6. Other Conditions (Tay Scah Disease)
12.4. By Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Polymerase Chain Reaction (PCR)
12.4.2. DNA Sequencing
12.4.3. Microarrays
12.4.4. Other Technologies
12.5. By End-User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Hospitals
12.5.2. Reference Laboratories
12.5.3. Physician Offices & Clinics
12.5.4. Other End Users
12.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Poland
12.6.8. Rest of Europe
12.7. Europe Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 – 2028
12.8. Europe Carrier Screening Market Dynamics – Trends
13. Asia-Pacific Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
13.1. By Method Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.1. Molecular Screening Test
13.1.2. Biochemical Screening Test
13.2. By Type of Carrier Screening Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Expanded Carrier Screening
13.2.1.1. Customized Panel Testing
13.2.1.2. Predesigned Panel Testing
13.2.2. Targeted Disease Carrier Screening
13.3. By Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Cystic Fibrosis
13.3.2. Fragile X-Syndrome
13.3.3. Sickele Cell Disease
13.3.4. Spinal Muscular Atrophy
13.3.5. Alphathalassemia
13.3.6. Other Conditions (Tay Scah Disease)
13.4. By Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Polymerase Chain Reaction (PCR)
13.4.2. DNA Sequencing
13.4.3. Microarrays
13.4.4. Other Technologies
13.5. By End-User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Hospitals
13.5.2. Reference Laboratories
13.5.3. Physician Offices & Clinics
13.5.4. Other End Users
13.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 – 2028
13.8. Asia-Pacific Carrier Screening Market Dynamics – Trends
14. Latin America Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
14.1. By Method Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.1. Molecular Screening Test
14.1.2. Biochemical Screening Test
14.2. By Type of Carrier Screening Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Expanded Carrier Screening
14.2.1.1. Customized Panel Testing
14.2.1.2. Predesigned Panel Testing
14.2.2. Targeted Disease Carrier Screening
14.3. By Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Cystic Fibrosis
14.3.2. Fragile X-Syndrome
14.3.3. Sickele Cell Disease
14.3.4. Spinal Muscular Atrophy
14.3.5. Alphathalassemia
14.3.6. Other Conditions (Tay Scah Disease)
14.4. By Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Polymerase Chain Reaction (PCR)
14.4.2. DNA Sequencing
14.4.3. Microarrays
14.4.4. Other Technologies
14.5. By End-User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Hospitals
14.5.2. Reference Laboratories
14.5.3. Physician Offices & Clinics
14.5.4. Other End Users
14.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Argentina
14.6.4. Rest of Latin America
14.7. Latin America Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 – 2028
14.8. Latin America Carrier Screening Market Dynamics – Trends
15. Middle East and Africa Carrier Screening Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
15.1. By Method Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.1. Molecular Screening Test
15.1.2. Biochemical Screening Test
15.2. By Type of Carrier Screening Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.2.1. Expanded Carrier Screening
15.2.1.1. Customized Panel Testing
15.2.1.2. Predesigned Panel Testing
15.2.2. Targeted Disease Carrier Screening
15.3. By Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Cystic Fibrosis
15.3.2. Fragile X-Syndrome
15.3.3. Sickele Cell Disease
15.3.4. Spinal Muscular Atrophy
15.3.5. Alphathalassemia
15.3.6. Other Conditions (Tay Scah Disease)
15.4. By Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. Polymerase Chain Reaction (PCR)
15.4.2. DNA Sequencing
15.4.3. Microarrays
15.4.4. Other Technologies
15.5. By End-User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Hospitals
15.5.2. Reference Laboratories
15.5.3. Physician Offices & Clinics
15.5.4. Other End Users
15.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. Israel
15.6.3. South Africa
15.6.4. Rest of MEA
15.7. MEA Carrier Screening Market – Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 – 2028
15.8. MEA Carrier Screening Market Dynamics – Trends
16. Competition Landscape 
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Material & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Plastixx FFS Technologies
16.2.2. Centogene N.V
16.2.3. LifeCell International Pvt. Ltd.
16.2.4. Thermo Fisher Scientific Inc.
16.2.5. 23Andme Inc.
16.2.6. F. Hoffmann-La Roche AG
16.2.7. Abbott Laboratories
16.2.8. Illumina Inc.
16.2.9. Autogenomics Inc.
16.2.10. Myriad Genetics
16.2.11. Cepheid (Danaher Corporation)
16.2.12. Luminex Corporation
16.2.13. Sequenom Inc. (Laboratory Corporation of America Holdings)
17. Research Methodology
18. Key Assumptions and Acronyms

Reviews

There are no reviews yet.

Be the first to review “Carrier Screening Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX